Product image of Zejula (Niraparib) supplied by GNH India

Zejula

Active Ingredient:
Niraparib
Origin:
EU

Zejula (Niraparib)

Zejula (niraparib) is an oral prescription medication used for certain types of ovarian, fallopian tube, or primary peritoneal cancer. It belongs to a class of drugs known as PARP inhibitors, designed to help slow cancer progression. This medication is taken once daily in capsule form. Always follow your healthcare provider's guidance when using Zejula.

Manufacturer / TM Owner

Glaxosmithkline (Ireland) Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zejula (niraparib) is primarily used for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. It is also indicated for the maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who have responded to first-line platinum-based chemotherapy. Zejula is designed to help delay cancer progression in these patients.

Side Effects

  • Zejula (niraparib) works by helping to prevent cancer cells from repairing their DNA, which may slow or stop their growth. Patients may experience side effects such as nausea, fatigue, or changes in blood cell counts. Regular monitoring is important to manage any potential effects. Individual responses to the medication can vary.

Precautions & Warnings

  • Zejula should be taken exactly as prescribed by a healthcare provider. It is important to discuss your full medical history, including any blood disorders or liver problems, before starting treatment. Patients should report any unusual symptoms, such as severe fatigue or signs of infection, to their doctor promptly. Keep this medication out of reach of children.

Avoid Interactions

  • Zejula may interact with other medications, including certain antidepressants, antifungals, and blood thinners. Avoid grapefruit products while taking this medication, as they may affect how it works. Always inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using. Regular blood tests may be required to monitor for interactions.

Frequently Asked Questions

Zejula is used for maintenance treatment of certain ovarian, fallopian tube, or primary peritoneal cancers in adults who have responded to platinum-based chemotherapy.

Zejula is taken orally once daily, with or without food, as prescribed by a healthcare provider.

Common side effects may include nausea, fatigue, and changes in blood cell counts. Always consult your doctor if side effects are severe or persistent.

Zejula may interact with other medications. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Zejula may not be suitable for everyone. Discuss your full medical history with your doctor to determine if it is the right treatment for you.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Niraparib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT